WO2005017207A3 - Methods and compositions for detecting colon cancers - Google Patents
Methods and compositions for detecting colon cancers Download PDFInfo
- Publication number
- WO2005017207A3 WO2005017207A3 PCT/US2004/026478 US2004026478W WO2005017207A3 WO 2005017207 A3 WO2005017207 A3 WO 2005017207A3 US 2004026478 W US2004026478 W US 2004026478W WO 2005017207 A3 WO2005017207 A3 WO 2005017207A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- colon cancers
- detecting colon
- vimentin
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04781201.1A EP1660683B1 (en) | 2003-08-14 | 2004-08-16 | Methods and compositions for detecting colon cancers |
CA2535910A CA2535910C (en) | 2003-08-14 | 2004-08-16 | Methods and compositions for detecting colon cancers |
JP2006523432A JP4781267B2 (en) | 2003-08-14 | 2004-08-16 | Method and composition for detecting colorectal cancer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49506403P | 2003-08-14 | 2003-08-14 | |
US60/495,064 | 2003-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005017207A2 WO2005017207A2 (en) | 2005-02-24 |
WO2005017207A3 true WO2005017207A3 (en) | 2005-10-27 |
Family
ID=34193270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/026478 WO2005017207A2 (en) | 2003-08-14 | 2004-08-16 | Methods and compositions for detecting colon cancers |
Country Status (5)
Country | Link |
---|---|
US (4) | US7485420B2 (en) |
EP (1) | EP1660683B1 (en) |
JP (2) | JP4781267B2 (en) |
CA (1) | CA2535910C (en) |
WO (1) | WO2005017207A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11845991B2 (en) | 2009-02-03 | 2023-12-19 | Exact Sciences Corporation | Fecal sample processing and analysis comprising detection of blood |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003213107A1 (en) | 2002-02-15 | 2003-09-09 | Exact Sciences Corporation | Methods for analysis of molecular events |
WO2003099313A1 (en) * | 2002-05-23 | 2003-12-04 | Purdue Research Foundation | Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target |
JP4781267B2 (en) * | 2003-08-14 | 2011-09-28 | ケース ウエスタン リザーブ ユニバーシティ | Method and composition for detecting colorectal cancer |
US8415100B2 (en) * | 2003-08-14 | 2013-04-09 | Case Western Reserve University | Methods and compositions for detecting gastrointestinal and other cancers |
WO2005111244A2 (en) * | 2004-05-10 | 2005-11-24 | Exact Sciences Corporation | Methods for detecting a mutant nucleic acid |
WO2006026654A2 (en) | 2004-08-27 | 2006-03-09 | Exact Sciences Corporation | Method for detecting a recombinant event |
WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
WO2006094149A2 (en) * | 2005-03-01 | 2006-09-08 | Exact Sciences Corporation | Methods and compositions for detecting adenoma |
US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
WO2006128140A2 (en) * | 2005-05-27 | 2006-11-30 | Dana-Farber Cancer Institute, Inc. | Gene methylation and expression |
JP2011501674A (en) * | 2007-10-23 | 2011-01-13 | クリニカル・ジェノミックス・プロプライエタリー・リミテッド | Diagnosis of type 2 neoplasia (NEOPLASMS-II) |
JPWO2010113529A1 (en) | 2009-04-03 | 2012-10-04 | 株式会社エイアンドティー | Colorectal tumor detection method |
EP3327139A1 (en) * | 2009-04-06 | 2018-05-30 | The Johns Hopkins University | Digital quantification of dna methylation |
US8642271B2 (en) * | 2009-08-27 | 2014-02-04 | Case Western Reserve University | Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer |
US20130012410A1 (en) * | 2010-03-29 | 2013-01-10 | Mayo Foundation For Medical Education And Research | Methods and materials for detecting colorectal cancer and adenoma |
WO2012052844A1 (en) * | 2010-10-19 | 2012-04-26 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection of bladder cancer |
US8916344B2 (en) * | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
US9637792B2 (en) | 2011-02-02 | 2017-05-02 | Mayo Foundation For Medical Education And Research | Digital sequence analysis of DNA methylation |
GB201107466D0 (en) | 2011-05-05 | 2011-06-15 | Loktionov Alexandre | Device and method for non-invasive collection of colorectal mucocellular layer and disease detection |
US20150072866A1 (en) * | 2012-03-20 | 2015-03-12 | Exact Sciences Corporation | Marker panel for detecting cancer |
US9994911B2 (en) | 2013-03-14 | 2018-06-12 | Mayo Foundation For Medical Education And Research | Detecting neoplasm |
US10253358B2 (en) | 2013-11-04 | 2019-04-09 | Exact Sciences Development Company, Llc | Multiple-control calibrators for DNA quantitation |
CA3147619A1 (en) | 2013-12-12 | 2015-06-18 | Case Western Reserve University | Device for collecting a biological sample |
WO2015095689A1 (en) | 2013-12-19 | 2015-06-25 | Exact Sciences Corporation | Synthetic nucleic acid control molecules |
WO2015153284A1 (en) | 2014-03-31 | 2015-10-08 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasm |
WO2016085944A1 (en) * | 2014-11-24 | 2016-06-02 | Case Western Reserve University | Diagnostic and therapeutic targeting of dnmt-1 associated rna in human cancer |
US10030272B2 (en) | 2015-02-27 | 2018-07-24 | Mayo Foundation For Medical Education And Research | Detecting gastrointestinal neoplasms |
CN108138235B (en) | 2015-08-31 | 2022-04-15 | 梅约医药教育及研究基金会 | Detection of gastric tumors |
EP3443089A4 (en) | 2016-04-14 | 2020-04-22 | Mayo Foundation for Medical Education and Research | Detecting pancreatic high-grade dysplasia |
US10370726B2 (en) | 2016-04-14 | 2019-08-06 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasia |
CA3029866A1 (en) * | 2016-07-06 | 2018-01-11 | Case Western Reserve University | Methods and compositions for detecting esophageal neoplasias and/or metaplasias in the esophagus |
JP7356349B2 (en) | 2017-02-28 | 2023-10-04 | マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ | prostate cancer detection |
EP3717644A4 (en) | 2017-11-30 | 2021-12-29 | Mayo Foundation for Medical Education and Research | Detecting breast cancer |
EP3856903A4 (en) | 2018-09-27 | 2022-07-27 | Grail, LLC | Methylation markers and targeted methylation probe panel |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148327A1 (en) * | 2000-04-06 | 2003-08-07 | Alexander Olek | Diagnosis of diseases associated with metastasis |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853975A (en) * | 1994-08-23 | 1998-12-29 | Millennium Pharmaceuticals, Inc. | Methods for identifying compositions for the treatment of body weight disorders, including obesity |
US6017704A (en) * | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
US5786146A (en) * | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
JP4151751B2 (en) * | 1999-07-22 | 2008-09-17 | 第一三共株式会社 | New bicyclonucleoside analogues |
DE10019058A1 (en) * | 2000-04-06 | 2001-12-20 | Epigenomics Ag | Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
JP2004516821A (en) | 2000-09-01 | 2004-06-10 | エピゲノミクス アーゲー | Method for quantifying the degree of methylation of specific cytosine in sequence context 5-CpG-3 on genomic DNA |
AUPR142500A0 (en) * | 2000-11-13 | 2000-12-07 | Human Genetic Signatures Pty Ltd | A peptide nucleic acid-based assay for the detection of specific nucleic acid sequences |
DE10056802B4 (en) * | 2000-11-14 | 2005-06-16 | Epigenomics Ag | Method for the detection of methylation conditions for toxicological diagnostics |
JP4781267B2 (en) | 2003-08-14 | 2011-09-28 | ケース ウエスタン リザーブ ユニバーシティ | Method and composition for detecting colorectal cancer |
GB0700374D0 (en) * | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
US7785772B2 (en) * | 2007-01-23 | 2010-08-31 | Mayo Foundation For Medical Education And Research | Detecting methylated mammalian nucleic acid in stool |
-
2004
- 2004-08-16 JP JP2006523432A patent/JP4781267B2/en not_active Expired - Fee Related
- 2004-08-16 US US10/920,119 patent/US7485420B2/en active Active
- 2004-08-16 WO PCT/US2004/026478 patent/WO2005017207A2/en active Application Filing
- 2004-08-16 EP EP04781201.1A patent/EP1660683B1/en active Active
- 2004-08-16 CA CA2535910A patent/CA2535910C/en active Active
-
2008
- 2008-06-27 US US12/215,608 patent/US8481707B2/en active Active
-
2009
- 2009-01-30 US US12/322,202 patent/US7964353B2/en not_active Expired - Fee Related
-
2011
- 2011-05-11 US US13/105,588 patent/US8221977B2/en active Active
- 2011-05-11 JP JP2011105798A patent/JP5575053B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148327A1 (en) * | 2000-04-06 | 2003-08-07 | Alexander Olek | Diagnosis of diseases associated with metastasis |
Non-Patent Citations (6)
Title |
---|
DOMAGALA W ET AL: "VIMENTIN IS PREFERENTIALLY EXPRESSED IN HUMAN BREAST CARCINOMAS WITH LOW ESTROGEN RECEPTOR AND HIGH KI-67 GROWTH FRACTION", AMERICAN JOURNAL OF PATHOLOGY, PHILADELPHIA, PA, US, vol. 136, no. 1, January 1990 (1990-01-01), pages 219 - 227, XP008006515, ISSN: 0002-9440 * |
EDEN SHARON ET AL: "Role of DNA methylation in the regulation of transcription", CURRENT OPINION IN GENETICS AND DEVELOPMENT, vol. 4, no. 2, 1994, pages 255 - 259, XP009044081, ISSN: 0959-437X * |
IZMAILOVA E S ET AL: "A GC-box is required for expression of the human vimentin gene", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 235, no. 1-2, 22 July 1999 (1999-07-22), pages 69 - 75, XP004174740, ISSN: 0378-1119 * |
LANGA FRANCINA ET AL: "Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: An approach to study the role of vimentin in tumorigenesis", JOURNAL OF CELL SCIENCE, vol. 113, no. 19, October 2000 (2000-10-01), pages 3463 - 3472, XP002318359, ISSN: 0021-9533 * |
LI HUI ET AL: "SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 100, no. 14, 8 July 2003 (2003-07-08), pages 8412 - 8417, XP001205249, ISSN: 0027-8424 * |
PETKO ZSOLT ET AL: "Aberrantly methylated CDKN2A, MGMT and hMLH1 are biomarkers for colon adenomas and colon adenocarcinomas.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 44, July 2003 (2003-07-01), & 94TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; WASHINGTON, DC, USA; JULY 11-14, 2003, pages 698, XP001205250, ISSN: 0197-016X * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11845991B2 (en) | 2009-02-03 | 2023-12-19 | Exact Sciences Corporation | Fecal sample processing and analysis comprising detection of blood |
Also Published As
Publication number | Publication date |
---|---|
US20050106593A1 (en) | 2005-05-19 |
US7964353B2 (en) | 2011-06-21 |
JP2011200237A (en) | 2011-10-13 |
US20110217708A1 (en) | 2011-09-08 |
US7485420B2 (en) | 2009-02-03 |
EP1660683A2 (en) | 2006-05-31 |
US8221977B2 (en) | 2012-07-17 |
US20100009359A1 (en) | 2010-01-14 |
US8481707B2 (en) | 2013-07-09 |
JP2007502121A (en) | 2007-02-08 |
EP1660683B1 (en) | 2017-04-19 |
JP5575053B2 (en) | 2014-08-20 |
JP4781267B2 (en) | 2011-09-28 |
US20100209906A1 (en) | 2010-08-19 |
CA2535910C (en) | 2016-04-26 |
WO2005017207A2 (en) | 2005-02-24 |
CA2535910A1 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005017207A3 (en) | Methods and compositions for detecting colon cancers | |
WO2003031932A3 (en) | Methods and compositions for detecting colon cancers | |
WO2001036685A3 (en) | Differential gene expression in cancer | |
EP2671581B8 (en) | Compositions and methods for treating cancer | |
WO2005027962A3 (en) | 4’-thionucleosides and oligomeric compounds | |
WO2001096584A3 (en) | Materials and methods for the control of nematodes | |
WO2005023824A3 (en) | Methods for inhibiting tumor cell proliferation | |
EP1750771A4 (en) | Pancreatic islet microrna and methods for inhibiting same | |
WO2007009755A3 (en) | Compositions and methods for cancer diagnostics comprising pan-cancer markers | |
WO2003050243A3 (en) | Novel genes encoding colon cancer antigens | |
WO2001052904A3 (en) | Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides | |
MX276236B (en) | Coating compositions containing reactive diluents and methods. | |
AU2003300368A1 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
WO2008061020A3 (en) | Methods of treating, diagnosing or detecting cancer | |
WO2004044160A3 (en) | Muc1 interference rna compositions and methods derived therefrom | |
WO2007035709A3 (en) | Novel crystal forms of irinotecan hydrochloride | |
DE60200449D1 (en) | Silicon nitride - Tungsten carbide sintered composite material, process for its production and glow plug containing it | |
WO2004058158A3 (en) | Treatment of metastatic cancer with the b-subunit of shiga toxin | |
WO2004031402A3 (en) | Methylation profile of cancer | |
WO2003035889A3 (en) | Compositions and methods for bacteria detection | |
AU2003252249A1 (en) | Method of judging cancer based on the expression of homeobox gene | |
WO2004091484A3 (en) | Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en22-one 16-0-(2-0-4-methoxybenzoyl-beta-d-xylopyranosyl)-(1->3)-(2-0acetyl-alpha-l-arabinopyranoside)] or osw-1 and its derivatives for cancer therapeutics | |
WO2007003397A3 (en) | Method and nucleic acids for the improved treatment of cancers | |
WO2004096021A3 (en) | Global analysis of transposable elements as molecular markers of cancer | |
WO2004050834A3 (en) | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006523432 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 2535910 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2004781201 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004781201 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004781201 Country of ref document: EP |